Rain Therapeutics Inc. (RAIN) Tops Q1 EPS by 6c

Rain Therapeutics Inc. (NASDAQ: RAIN) reported Q1 EPS of ($0.56), $0.06 better than the analyst estimate of ($0.62).

For earnings history and earnings-related data on Rain Therapeutics Inc. (RAIN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Movano (MOVE) Misses Q2 EPS by 195c
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c